Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose growth hormone in impaired glucose tolerance
2004-004719-43Phase 4Terminated
- Sponsor
- University of Cambridge
- Start
- May 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of somatropin in prediabetes, sponsored by University of Cambridge. Primary endpoint: Improvement in postload glucose tolerance. Started May 2005; status: terminated.
02
Drugs
somatropin
03
Conditions
prediabetes
Beyond the preview
Go deeper on 2004-004719-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004719-43.